Back to News
investment

First Week of CMPX January 2027 Options Trading

BNK Invest
Loading...
5 min read
0 likes
⚡ Quantum Brief
New January 2027 options for Compass Therapeutics (CMPX) began trading this week, offering 322-day contracts with elevated time-value premiums for sellers of puts or calls. A $5.00 strike put, priced at 30 cents, lets sellers collect a premium while committing to buy shares at a 13% discount to the current $5.76 price, with an 82% chance of expiring worthless. The $7.00 strike call, bid at $1.50, offers a 47.57% potential return if assigned, though it’s 22% out-of-the-money with a 23% expiration probability. Implied volatility for the contracts is exceptionally high (173–178%), far exceeding CMPX’s trailing 12-month volatility of 75%, signaling aggressive market pricing. Analysts highlight the YieldBoost potential: 6.8% annualized for puts, 29.52% for covered calls if contracts expire worthless.
AI Audio Summary
0:00 / 0:00
Click to play
nicolas-arnold-e_xLO2vmiQI-unsplash.jpg
Quantum News · Media Library

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Markets CMPX First Week of CMPX January 2027 Options Trading February 27, 2026 — 10:37 am EST Written by BNK Invest for BNK Invest-> Investors in Compass Therapeutics Inc (Symbol: CMPX) saw new options become available this week, for the January 2027 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 322 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

At Stock Options Channel, our YieldBoost formula has looked up and down the CMPX options chain for the new January 2027 contracts and identified one put and one call contract of particular interest.The put contract at the $5.00 strike price has a current bid of 30 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $5.00, but will also collect the premium, putting the cost basis of the shares at $4.70 (before broker commissions). To an investor already interested in purchasing shares of CMPX, that could represent an attractive alternative to paying $5.76/share today. Because the $5.00 strike represents an approximate 13% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 82%.

Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 6.00% return on the cash commitment, or 6.80% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Compass Therapeutics Inc, and highlighting in green where the $5.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $7.00 strike price has a current bid of $1.50. If an investor was to purchase shares of CMPX stock at the current price level of $5.76/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $7.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 47.57% if the stock gets called away at the January 2027 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if CMPX shares really soar, which is why looking at the trailing twelve month trading history for Compass Therapeutics Inc, as well as studying the business fundamentals becomes important. Below is a chart showing CMPX's trailing twelve month trading history, with the $7.00 strike highlighted in red: Considering the fact that the $7.00 strike represents an approximate 22% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 23%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 26.04% boost of extra return to the investor, or 29.52% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 173%, while the implied volatility in the call contract example is 178%.Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 251 trading day closing values as well as today's price of $5.76) to be 75%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com. Top YieldBoost Calls of the S&P 500 » Also see: • LYTS Insider Buying • Top 10 Hedge Funds Holding AWK • Top Ten Hedge Funds Holding AGU The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags MarketsStocksOptions BNK Invest BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally. LYTS Insider Buying-> Top 10 Hedge Funds Holding AWK-> Top Ten Hedge Funds Holding AGU-> More articles by this source-> Stocks mentioned CMPX More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Read Original

Source Information

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.